// STATE LEGISLATION TRACKER

Ohio HB 963: Revise the law governing the practice of physician assistants

⚖️ MIXED for peptide users 👤 MEDIUM user impact 📜 Status: In committee

State: Ohio
Bill: HB 963
Session: 136
Filed: 2026-06-09
Read the bill: OpenStates →
Last reviewed: 2026-11-02

Plain-English Summary

Ohio HB963 aims to modernize the practice of physician assistants (PAs) by shifting from a "supervision" to a "collaboration" model with physicians. This bill does not directly address peptide regulation but could indirectly impact how PAs prescribe and manage treatments, including peptides, by expanding their scope and autonomy.

Key Points

PAs will collaborate with physicians, not just be supervised.
Removes physician liability for PA actions.
PAs can practice to the full extent of their training.
Expands PA prescriptive authority.
Streamlines PA practice and reduces administrative burdens.

What to Watch For

✓

Opportunity Expanded PA autonomy may increase access to diverse treatments, including peptides, if prescribing guidelines are clear.

Concern Broader PA prescribing powers could lead to increased off-label prescribing of peptides without clear oversight.

Note This bill focuses on PA practice modernization, not direct regulation of compounding pharmacies or specific drug classes.

Concern While not directly addressed, changes in PA scope could impact telehealth models for peptide delivery.

Where the Bill Stands

The bill has been introduced and referred to the Health committee in the Ohio House of Representatives.

· Ed. Our analysis pulls public bill metadata from OpenStates and is enriched with research-model context. We don't quote bill text we haven't read directly. If this bill matters to your practice or treatment access, read the official source linked above before taking action. We're an educational research directory, not a legal or medical reference.

Bill page generated 2026-11-04 · enriched via codex gpt-5.5
Source: OpenStates v3 API · View official bill · ← back to all laws